Related by context. All words. (Click for frequent words.) 72 elotuzumab 71 teriflunomide 70 bosutinib 70 riociguat 70 #mg BID [001] 69 iniparib 69 Traficet EN 69 pomalidomide 69 decitabine 69 CIMZIA TM 69 desvenlafaxine succinate 68 tocilizumab 68 motesanib 68 ACTEMRA TM 68 eltrombopag 68 briakinumab 68 INCB# [003] 68 axitinib 68 Telintra 68 pharmacodynamic properties 68 zalutumumab 68 posaconazole 68 achieved ACR# 68 diabetic neuropathic pain 68 Darusentan 68 PRT# 67 HuMax CD# 67 GSK# [001] 67 comparator arm 67 FOLPI 67 CIMZIA ™ 67 bicifadine 67 atrasentan 67 efficacy endpoint 67 pertuzumab 67 ximelagatran 67 Durezol 67 sunitinib malate 67 TNF inhibitor 67 PROMACTA 67 active comparator 67 tipranavir 67 visilizumab 67 MAGE A3 ASCI 67 adalimumab 66 HuMax EGFr 66 Ophena TM 66 ProSavin 66 ibandronate 66 intermittent dosing 66 Tarceva TM 66 ZOLINZA 66 vidofludimus 66 ruboxistaurin 66 prucalopride 66 valopicitabine 66 Torisel 66 alvimopan 66 sorafenib Nexavar 66 bardoxolone methyl 66 mg kg dose 66 ARCOXIA 66 metaglidasen 66 safinamide 66 Triolex 66 APTIVUS R 66 brivaracetam 66 ACZ# 66 abiraterone acetate 66 TBC# 66 Aflibercept 66 RoACTEMRA 66 ruxolitinib 66 CCX# 66 vandetanib 66 RSD# oral 66 AEGR 66 antiarrhythmic 66 pazopanib 66 ixabepilone 65 AGILECT R 65 mg dose 65 EVIZON 65 Doxil ® 65 teduglutide 65 NATRECOR R 65 tipranavir r 65 evaluating tivozanib 65 HuLuc# 65 pamidronate 65 oral prodrug 65 chlorambucil 65 cediranib 65 oral rivaroxaban 65 tanespimycin 65 ocrelizumab 65 neratinib 65 achieved statistical significance 65 BRIM2 65 PDE4 inhibitor 65 placebo controlled clinical trials 65 baminercept 65 parecoxib 65 tapentadol ER 65 XmAb# 65 azacitidine 65 forodesine 65 APTIVUS r 65 mycophenolate mofetil 65 CIMZIA TM certolizumab pegol 65 sunitinib 65 tasocitinib 65 S/GSK# 65 maximally tolerated dose 65 TroVax ® 65 olmesartan 65 Apoptone 65 cabazitaxel 65 mapatumumab 65 obatoclax 65 ALGRX 65 romidepsin 65 CA4P 65 alefacept 65 methotrexate monotherapy 65 pegylated interferon alfa 2b 65 cisplatin vinorelbine 65 galiximab 65 adalimumab Humira 65 Virulizin ® 65 idraparinux 65 cariprazine 65 goserelin 65 Panzem R NCD 65 placebo controlled clinical 65 phase IIa clinical 65 budesonide foam 65 antitumor effect 65 Archexin 65 relapsed MM 65 GFT# 65 NATRECOR ® 65 Targretin 65 tenofovir emtricitabine 64 Xanafide 64 cannabinor 64 PegIntron 64 tirofiban 64 BRAF inhibitor 64 enzastaurin 64 Octreolin 64 analgesic efficacy 64 temsirolimus 64 favorable tolerability 64 salmeterol fluticasone 64 MGd 64 zolmitriptan 64 Golimumab 64 tolvaptan 64 lenalidomide dexamethasone 64 irbesartan 64 atazanavir ritonavir 64 plasma kallikrein inhibitor 64 lumiliximab 64 mcg dose 64 dose cohort 64 antithrombotic 64 vicriviroc 64 NLX P# 64 solifenacin 64 mTOR inhibitors 64 peginterferon alfa 2b 64 mcg BID 64 iclaprim 64 HGS ETR2 64 certolizumab 64 bendamustine 64 Gabapentin GR 64 olaparib 64 Fludara 64 oral FTY# 64 TG# [003] 64 GAMMAGARD 64 Nexavar sorafenib 64 regorafenib 64 Dasatinib 64 clevidipine 64 lasofoxifene 64 Rebif ® 64 EndoTAGTM 1 64 ponatinib 64 mg/m2 dose 64 receptor tyrosine kinase inhibitor 64 Symadex 64 ULORIC 64 PS# [001] 64 PSN# [002] 64 dexpramipexole 64 AMEVIVE 64 Vitaxin 64 splenectomized patients 64 Cimzia TM 64 μg dose 64 fosbretabulin 64 alemtuzumab Campath 64 Aplidin 64 mRCC 64 TNF alpha inhibitor 64 antitumor effects 64 daclizumab 64 Xinlay 64 IRX 2 64 Oral NKTR 64 BAY #-# 64 ritonavir boosted 64 oxymorphone ER 64 etanercept 64 lurasidone 64 glatiramer 64 INCB# [001] 64 anticancer activity 64 Capesaris 64 mg QD 64 ganetespib 64 rilonacept 64 plus dexamethasone 64 VA# [002] 64 mg BID 64 HCV RESPOND 2 64 SinuNase 64 anti TNFs 64 interferon ribavirin 64 mitoxantrone 64 edifoligide 64 Phase 2a trial 64 RLY# 64 JAK inhibitors 64 odanacatib 64 oxycodone CR 64 ZD# [001] 64 Tasimelteon 64 Nuvion 64 CANCIDAS 64 JAK inhibitor 64 NV1FGF 64 Peg IFN 64 INCB# [002] 64 otelixizumab 64 Fibrillex TM 64 DAPT 64 edoxaban 64 QT QTc 64 pharmacodynamic profile 64 HuMax CD4 63 RRMS patients 63 phase IIb study 63 docetaxel Taxotere ® 63 tremelimumab 63 DU #b 63 atacicept 63 somatostatin analog 63 Aptivus ® 63 Phenoptin 63 RLAI 63 OHR/AVR# 63 dosing cohort 63 phase IIb trial 63 Stelara 63 intravenous cyclophosphamide 63 ATACAND 63 desvenlafaxine 63 plus prednisone 63 docetaxel chemotherapy 63 subcutaneously administered 63 noninferiority 63 cangrelor 63 velafermin 63 efalizumab 63 Androxal TM 63 receptor inhibitor 63 tecarfarin 63 Q#IR 63 bosentan 63 FluCAM 63 lomitapide 63 Phase IIa trial 63 LEXIVA r 63 adjuvant colon cancer 63 Interferon beta 1b 63 recurrent GBM 63 mTOR inhibitor 63 piperacillin tazobactam 63 heavily pretreated 63 antitumor activity 63 IFN α 63 NEVO ™ 63 PASI scores 63 fostamatinib 63 gefitinib Iressa 63 ELACYT 63 elagolix 63 fingolimod 63 cobicistat 63 #mg dose [002] 63 aclidinium 63 GOUT 63 fluvastatin 63 ulimorelin 63 administered subcutaneously 63 mecamylamine 63 vismodegib 63 Triapine R 63 aldosterone antagonists 63 pegylated interferons 63 enoximone 63 carboplatin paclitaxel 63 PREZISTA r 63 achieved PASI 63 REMINYL ® 63 Phase Ib study 63 pegaptanib 63 Zybrestat 63 MACUGEN 63 amrubicin 63 phase IIb 63 RG# [001] 63 STRIDE PD 63 RAPAFLO R 63 MoxDuo IR 63 preclinically 63 hour bronchodilation 63 favorable pharmacokinetic profile 63 pradefovir 63 ACTEMRA 63 MoxDuo 63 tezampanel 63 plus methotrexate 63 cinacalcet 63 OMNARIS HFA 63 5-FU/LV 63 intravenous dosing 63 sorafenib tablets 63 Imprime PGG 63 CaPre TM 63 nab paclitaxel 63 infusional 5-FU/LV 63 urocortin 2 63 Ticagrelor 63 intravenous bisphosphonates 63 Proxinium TM 63 Neurodex 63 PROSTVAC TM 63 clodronate 63 dosage regimens 63 Panzem R 63 fluticasone salmeterol 63 Pharmacokinetic studies 63 BZL# 63 alpha blocker 63 Pegasys plus Copegus 63 phase Ib 63 alvespimycin 63 IFN beta 63 BoNTA 63 midstage clinical 63 aspirin clopidogrel 63 gemcitabine Gemzar 63 virologic response 63 QNEXA 63 Zemplar Capsules 63 CTAP# Capsules 63 alteplase 63 lipid lowering therapies 63 mertansine 63 Amplimexon 63 Emselex 63 aleglitazar 63 adefovir 63 ENMD # 63 Advagraf 63 darapladib 63 sargramostim 63 dose escalation phase 63 etravirine 63 antiangiogenic therapy 63 Perforomist Inhalation Solution 63 adecatumumab 63 clobazam 63 viral kinetics 63 sitaxsentan 63 #mg/day [002] 63 FOLFIRINOX 63 Elocalcitol 63 romiplostim 63 pimecrolimus 63 alpha 2a 63 Vernakalant 63 ARB telmisartan 62 humanized interleukin 6 62 #mg doses [002] 62 uric acid lowering 62 darunavir 62 liposomal doxorubicin 62 Ocrelizumab 62 LymphoStat B belimumab 62 APTIVUS 62 CYPHER Stent 62 pramipexole 62 neoadjuvant treatment 62 IBS C 62 BENICAR HCT 62 SCH # 62 anti leukemic 62 paliperidone ER 62 achieving PASI 62 VELCADE melphalan 62 ribavirin RBV 62 Pruvel 62 headache nasopharyngitis 62 gemcitabine carboplatin 62 GALNS 62 chemoradiotherapy 62 sustained virological response 62 metastatic hormone refractory 62 YONDELIS 62 BMS # 62 nilotinib 62 TYKERB 62 relapsed multiple myeloma 62 azficel T 62 varespladib 62 CR nPR 62 Kinoid 62 AZILECT R 62 timepoints 62 QVA# 62 ALA PDT 62 denufosol 62 Firazyr 62 Dapagliflozin 62 Itopride 62 Rezular 62 levosimendan 62 virological response 62 rolofylline 62 Synavive 62 rosuvastatin #mg 62 talabostat 62 RhuDex ® 62 docetaxel Taxotere R 62 Plicera 62 FROVA 62 SERMs 62 FFNS 62 Viramidine 62 Alzhemed TM 62 Phase IIb trials 62 HQK 62 corticosteroid therapy 62 hematologic toxicity 62 pramlintide metreleptin combination 62 RAPAFLO 62 dosing frequency 62 LT NS# 62 abatacept 62 canakinumab 62 candesartan cilexetil 62 recurrent glioblastoma multiforme 62 huN# DM1 62 oxcarbazepine 62 metastatic renal cell carcinoma 62 GRN# 62 INC# 62 hypercalcemia 62 atorvastatin #mg 62 6R BH4 62 Ambrisentan 62 mg/m2 cohort 62 Lenalidomide 62 8mg/kg 62 azilsartan medoxomil 62 FOLFOX6 62 xanthine oxidase inhibitor 62 GW# [003] 62 GLYX 62 PEG SN# 62 OMNARIS Nasal Spray 62 trastuzumab Herceptin ® 62 histone deacetylase HDAC inhibitor 62 interferon alfa 2b 62 Campath alemtuzumab 62 K ras mutations 62 rFVIIa 62 statistically significant efficacy 62 IPX# 62 TNF antagonist 62 vasomotor symptoms 62 mcg kg 62 thromboembolic events 62 tiotropium bromide 62 XGEVA 62 STELARA 62 AGILECT ® 62 zoledronate 62 Carfilzomib 62 Vfend 62 anti androgen 62 dacetuzumab 62 Factor VIIa 62 refractory gout 62 icatibant 62 Teriflunomide 62 dose cohorts 62 Sutent sunitinib 62 Bezielle 62 imiquimod cream 62 virus HCV protease inhibitor 62 opioid induced bowel dysfunction 62 Amrubicin 62 peginterferon 62 steroid dexamethasone 62 Asentar 62 caspofungin 62 otamixaban 62 Promacta 62 Empatic 62 evaluating REVLIMID 62 intravesical therapy 62 IGF 1R inhibitor 62 nucleoside analog 62 Factor Xa inhibitor 62 lesinurad 62 tolterodine ER 62 mitoxantrone plus 62 ustekinumab 62 IV bisphosphonates 62 biologic DMARD 62 anti angiogenic agents 62 pegylated liposomal doxorubicin 62 eniluracil 62 PF # [001] 62 methylnaltrexone 62 REMICADE ® 62 Chemophase 62 Diovan HCT 62 SYN# 62 CYT# 62 beta interferons 62 Zoraxel 62 elacytarabine 62 Benlysta belimumab 62 Mipomersen 62 HMG CoA reductase inhibitors 62 complete remissions 62 bicalutamide 62 complete cytogenetic response 62 antiplatelet agent 62 zileuton 62 tarenflurbil 62 Laquinimod 62 ALB # 62 pan HDAC inhibitor 62 EGFR inhibitors 62 Crestor rosuvastatin 62 lipid lowering therapy 62 daunorubicin 62 oral diclofenac 62 phase IIb clinical 62 Atacand 62 Tekamlo 62 genotypic resistance 62 CRx 62 cilostazol 62 CHOP chemotherapy 62 flutamide 62 REYATAZ R 62 metastatic RCC 62 gemifloxacin 62 orally administered inhibitor 62 SRT# [003] 62 pharmacokinetic characteristics 62 COPAXONE R 62 rosuvastatin Crestor 62 casopitant 62 DAVANAT 62 angiogenesis inhibitor 62 rotigotine 62 LymphoStat B 62 motavizumab 62 custirsen 62 guanfacine extended release 62 Troxatyl 62 Lu AA# 62 Pimavanserin 62 pharmacodynamic effects 62 ancrod 62 glatiramer acetate 62 radezolid 62 Serdaxin 62 ribavirin therapy 62 dasatinib 62 lintuzumab 62 SNT MC# 61 radiation sensitizer 61 cobiprostone 61 TACI Ig 61 pregabalin Lyrica 61 mcg albinterferon alfa 2b 61 docetaxel Taxotere 61 allogeneic SCT 61 oral salmon calcitonin 61 agomelatine 61 ILLUMINATE 61 tramiprosate Alzhemed TM 61 thalidomide Thalomid 61 MNTX 61 perampanel 61 prednisone prednisolone plus 61 Vandetanib 61 FOLFOX4 61 palifermin 61 anakinra 61 oral methylnaltrexone 61 EGFR tyrosine kinase inhibitor 61 estramustine 61 Elitek 61 TORISEL 61 cetuximab Erbitux R 61 octreotide LAR 61 lacosamide 61 Plenaxis TM 61 nicardipine 61 PXD# 61 erlotinib Tarceva 61 aplindore 61 Votrient 61 divalproex sodium 61 DOXIL 61 Betaferon R 61 dopamine partial agonist 61 IR prednisone 61 lintuzumab SGN 61 serum cortisol 61 ZACTIMA 61 darunavir ritonavir 61 Fablyn 61 Starlix 61 cardioprotective effects 61 HBeAg negative patients 61 plus prednisone prednisolone 61 Phase #/#a trial 61 clazosentan 61 eosinophilic asthma 61 pregabalin 61 Femara letrozole 61 octreotide 61 HGS# 61 esomeprazole 61 mGluR5 NAM 61 eptifibatide 61 sitagliptin Januvia 61 BAL# [002] 61 glargine 61 fosamprenavir 61 aflibercept 61 TNF antagonists 61 teriparatide 61 anidulafungin 61 urate lowering therapy 61 PEG PAL 61 AZD# 61 MabCampath 61 prospectively defined 61 Azedra 61 oral levofloxacin 61 tolerability profiles 61 vivo potency 61 Actilon 61 Phase 2b trial 61 selective modulator 61 Arranon 61 SCIg 61 Evoltra ® 61 efficacy tolerability 61 pioglitazone HCl 61 rFIXFc 61 TMC# r 61 inecalcitol 61 cilengitide 61 PegIFN RBV 61 MYCAMINE 61 Sprycel dasatinib 61 ketorolac 61 Onbrez Breezhaler 61 painful diabetic neuropathy 61 EDEMA3 61 postoperative chemotherapy 61 #mg/day [001] 61 mcg doses 61 linaclotide 61 PRTX 61 thrombocytopenic 61 Fulvestrant 61 FTY# 61 #mg/m# [001] 61 imiquimod 61 pharmacodynamics PD 61 PEG Interferon lambda 61 taxane chemotherapy 61 AVODART 61 Vilazodone 61 tafamidis 61 Ixempra 61 Dacogen injection 61 Tavocept 61 oral Xeloda 61 esomeprazole Nexium 61 ketoconazole 61 trospium 61 avosentan 61 ozarelix 61 Phase #/#a 61 inhaled iloprost 61 gadobutrol 61 Interferon alpha 61 tegaserod 61 combinability 61 Proellex TM 61 canagliflozin 61 Sanofi Aventis Taxotere 61 APOPTONE 61 Telbivudine 61 Vertex telaprevir 61 #mg dose [001] 61 HBeAg positive patients 61 TELINTRA 61 ADP receptor antagonist 61 DexaSite 61 tesetaxel 61 oxaliplatin Eloxatin 61 pitavastatin 61 Celgene Revlimid 61 darunavir r 61 TELCYTA 61 Naproxcinod 61 factor TNF 61 liposomal formulation 61 CoFactor 61 mg doses 61 plasma renin activity 61 Pegasys ® 61 Phase 1a clinical 61 Targretin capsules 61 virologic failure 61 lopinavir r 61 serum phosphate levels 61 Vidaza azacitidine 61 null responder 61 LAF# 61 low dose cytarabine 61 HBeAg negative 61 doripenem 61 hsCRP levels 61 PEGylated interferon beta 1a 61 M6G 61 timepoint 61 paclitaxel eluting stents 61 events AEs 61 alkylating agent 61 paricalcitol 61 Flu Cy 61 Cimzia ® certolizumab pegol 61 corifollitropin alfa 61 telcagepant 61 Arikace 61 doxorubicin docetaxel 61 rindopepimut 61 refractory AML 61 LHRH agonists 61 hematological toxicity 61 torezolid phosphate 61 Adlea 61 Aloxi injection 61 Taxotere chemotherapy 61 oral cladribine 61 ImClone Erbitux 61 platelet inhibition 61 noninfectious uveitis 61 antiviral efficacy 61 dexamethasone Decadron 61 cetuximab Erbitux 61 protease inhibitor PI 61 Valdoxan 61 Glypromate 61 latanoprost 61 reslizumab 61 delafloxacin 61 nitazoxanide 61 ara C 61 BEMA TM LA 61 CCX# B 61 RSR# 61 VAPRISOL 61 concurrent chemoradiation 61 #mg BID [003] 61 Aclidinium 61 Serdolect 61 triamcinolone 61 Neuvenge 61 adipiplon 61 verteporfin 61 telbivudine 61 XIENCE V PROMUS Stent 61 immunomodulatory therapy 61 ceftaroline 61 Jevtana 61 microbiological eradication 61 TEMODAL 61 AXIRON ™ 61 selegiline 61 biliary tract cancer 61 CG# [003] 61 Phase Ib clinical 61 GVAX 61 deferiprone 61 fulvestrant 61 tacrolimus ointment 61 stage IIIB 61 pharmacokinetic parameters 61 peginterferon alfa 2a 61 pharmacokinetics PK 61 gastrointestinal stromal tumors GIST 61 CR# vcMMAE 61 SUTENT ® 61 tumor regressions 61 sapacitabine 61 renal toxicity 61 chemopreventive agent 61 TPI ASM8 61 relapsed MCL 61 demonstrated antitumor activity 61 Faslodex 61 trials RCTs 61 rNAPc2 61 sodium glucose cotransporter 61 CRLX# 61 ostarine 61 transaminases 61 MIRCERA 61 Diamyd ® 61 ToGA 61 Carvedilol 61 ZYBRESTAT 61 imatinib therapy 61 novel oral anticoagulant 61 TriRima 61 secondary efficacy endpoints 61 vorinostat 61 hyperphenylalaninemia HPA due 61 GRN#L 61 TNF inhibitors 61 standard chemotherapy regimen 61 PRADAXA 61 ezetimibe simvastatin 61 CYT# potent vascular disrupting 61 Tarceva erlotinib 61 LY# [002] 61 amprenavir 61 Alkeran 61 febuxostat 61 thymalfasin 61 AzaSite Plus 61 oral Hycamtin 61 topotecan 61 pharmacokinetic PK study 61 metastatic HRPC 61 hA# 61 ACAPODENE 61 rHuPH# 61 peg IFN 61 nadolol 60 non constipation irritable 60 NAbs 60 metastatic CRC 60 investigational therapies 60 coinfected patients 60 motesanib diphosphate 60 pyridostigmine 60 Tyrima 60 insulin degludec 60 Zolinza 60 cardiac toxicity 60 ALKS 60 Aurexis 60 Bicifadine 60 RhuDex 60 mCRC patients 60 IMC A# 60 orBec 60 mg TID 60 abacavir lamivudine 60 volociximab 60 indacaterol 60 Resolute DES 60 AQ4N 60 ATL/TV# 60 HIF PHI 60 pharmacodynamic 60 tolerability profile 60 sipuleucel T 60 albinterferon alfa 2b 60 clinically meaningful 60 ARIMIDEX 60 4mg/kg 60 mg qd 60 budesonide pMDI 60 Cancidas 60 non splenectomised 60 DACH platinum 60 IDX# 60 Ceflatonin 60 PEG Intron 60 LHRH analogues 60 aflibercept VEGF Trap 60 Cannabinor 60 Roche Xeloda 60 panitumumab Vectibix 60 vascular disrupting agent 60 gallium nitrate 60 pharmacokinetic profile 60 Velcade bortezomib 60 fenofibric acid 60 antiangiogenic agents 60 metastatic castration resistant 60 INVEGA ® 60 Rasagiline 60 Pemetrexed 60 HBeAg seroconversion 60 HMG CoA reductase inhibitor 60 KRAS mutations occur 60 MetMAb 60 esophageal candidiasis 60 CDP# 60 paclitaxel cisplatin 60 CBLC# 60 GnRH antagonist 60 relapsed SCLC 60 GnRH agonists 60 HER2 positive metastatic breast 60 OncoVEX GM CSF 60 MAP# 60 Pegasys peginterferon alfa 2a 60 NXL# 60 morphometric vertebral fractures 60 Natalizumab 60 corticosteroid dexamethasone 60 palonosetron 60 nonmetastatic prostate cancer 60 Allovectin 7 ® 60 balsalazide 60 BZA CE 60 trabedersen 60 AZT zidovudine Retrovir 60 oral deforolimus 60 blinatumomab 60 metastatic malignant melanoma 60 angiotensin receptor blocker ARB 60 cladribine tablets 60 rEV# 60 PEGylated Fab fragment 60 Protelos 60 EFFEXOR XR 60 midstage clinical trial 60 EOquin 60 plasma pharmacokinetics 60 pharmacokinetic PK 60 methotrexate MTX 60 ICA # 60 TREDAPTIVE 60 Herceptin trastuzumab 60 CYT# QbG# 60 MoxDuo ® IR 60 bezafibrate 60 concomitant medications 60 Betaferon ® 60 celgosivir 60 Phase 2b study 60 IOP lowering 60 FOLFOX6 chemotherapy regimen 60 weekly subcutaneous injections 60 secondary efficacy endpoint 60 partial agonist 60 Increlex ® 60 talactoferrin 60 muraglitazar 60 TKI therapy 60 Northera 60 DEB# 60 melphalan prednisone